Stay updated on Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page.

Latest updates to the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new page revision tag (v3.6.3) appears, replacing the previous v3.6.2 to reflect a minor update to the record.SummaryDifference0.1%

- Check17 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2. This reflects a newer version of the page rather than a substantive change to study information.SummaryDifference0.1%

- Check31 days agoChange DetectedThe page now indicates that recruitment has closed and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study, and an Intervention/Treatment label). It also removes the older 'Intervention / Treatment' label and the older 'Revision: v3.5.5' reference, signaling a minor reorganization and an updated page version.SummaryDifference0.4%

- Check38 days agoChange DetectedThe revision tag on the page updated from v3.5.4 to v3.5.5. This reflects a new version in the underlying system and does not indicate changes to the visible content.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page shows a new revision label, updating from v3.5.3 to v3.5.4. This represents an administrative version update to the study documentation rather than a substantive change to the study details.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a site/version update without changing the study details.SummaryDifference0.1%

Stay in the know with updates to Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page.